News & Press Releases

A Mintz team led by Richard Gervase, Member and Chair of the firm’s Royalty & Revenue Interest Financing Transactions Group, advised global investment firm Sixth Street in a non-dilutive, senior secured credit facility of up to $475 million for Apellis Pharmaceuticals. Apellis received $375 million in funding at close, with ability to access an additional $100 million under the facility at the Company’s option prior to September 2025, subject to the satisfaction of certain conditions.

The Boston Business Journal covered the arrival of Members Scott Lashway and Chris Lisy to the firm’s Data & Privacy Litigation and Investigations Practice. Scott will serve as the Co-chair of the Privacy & Cybersecurity practice.